These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 3139012

  • 1. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine.
    Gold LH, Swerdlow NR, Koob GF.
    Behav Neurosci; 1988 Aug; 102(4):544-52. PubMed ID: 3139012
    [Abstract] [Full Text] [Related]

  • 2. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
    Koob GF, Simon H, Herman JP, Le Moal M.
    Brain Res; 1984 Jun 15; 303(2):319-29. PubMed ID: 6430466
    [Abstract] [Full Text] [Related]

  • 3. Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system.
    Joyce EM, Koob GF.
    Psychopharmacology (Berl); 1981 Jun 15; 73(4):311-3. PubMed ID: 6789349
    [Abstract] [Full Text] [Related]

  • 4. Regulatory behaviour, exploration and locomotion following NMDA or 6-OHDA lesions in the rat nucleus accumbens.
    Weissenborn R, Winn P.
    Behav Brain Res; 1992 Nov 15; 51(2):127-37. PubMed ID: 1466779
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of mesocortical, mesolimbic, and mesostriatal dopamine depletion on spontaneous, conditioned, and drug-induced locomotor activity.
    Jones GH, Robbins TW.
    Pharmacol Biochem Behav; 1992 Nov 15; 43(3):887-95. PubMed ID: 1448483
    [Abstract] [Full Text] [Related]

  • 6. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C, Fibiger HC, Phillips AG.
    Brain Res; 1982 Dec 16; 253(1-2):185-93. PubMed ID: 6817850
    [Abstract] [Full Text] [Related]

  • 7. Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine.
    Clarke PB, Jakubovic A, Fibiger HC.
    Psychopharmacology (Berl); 1988 Dec 16; 96(4):511-20. PubMed ID: 3149775
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mesolimbic dopamine and early post-6-OHDA lesion enhanced responses to d-amphetamine.
    Lynch MR, Carey RJ.
    Pharmacol Biochem Behav; 1989 Feb 16; 32(2):577-80. PubMed ID: 2498910
    [Abstract] [Full Text] [Related]

  • 12. Functional recovery following transplantation of ventral mesencephalic cells in rat subjected to 6-OHDA lesions of the mesolimbic dopaminergic neurons.
    Nadaud D, Herman JP, Simon H, Le Moal M.
    Brain Res; 1984 Jun 18; 304(1):137-41. PubMed ID: 6331577
    [Abstract] [Full Text] [Related]

  • 13. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F, Ettenberg A, Koob GF.
    Psychopharmacology (Berl); 1989 Jun 18; 99(3):409-15. PubMed ID: 2574480
    [Abstract] [Full Text] [Related]

  • 14. Relationship of limbic dopamine levels to amphetamine- and anticholinergic-induced hyperactivity in the rat.
    Carey RJ.
    Biol Psychiatry; 1986 Mar 18; 21(3):317-21. PubMed ID: 3081055
    [No Abstract] [Full Text] [Related]

  • 15. Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat.
    Winn P, Robbins TW.
    Neuropharmacology; 1985 Jan 18; 24(1):25-31. PubMed ID: 3920545
    [Abstract] [Full Text] [Related]

  • 16. A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.
    Gold LH, Hubner CB, Koob GF.
    Psychopharmacology (Berl); 1989 Jan 18; 99(1):40-7. PubMed ID: 2571175
    [Abstract] [Full Text] [Related]

  • 17. Apomorphine-induced facilitation of intracranial self-stimulation following dopamine denervation of the nucleus accumbens.
    Strecker RE, Roberts DC, Koob GF.
    Pharmacol Biochem Behav; 1982 Nov 18; 17(5):1015-8. PubMed ID: 6817349
    [Abstract] [Full Text] [Related]

  • 18. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B, Marsden CD, Naylor RJ, Pycock CJ.
    Brain Res; 1976 Dec 10; 118(1):87-113. PubMed ID: 990957
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of D-amphetamine.
    Burns LH, Robbins TW, Everitt BJ.
    Behav Brain Res; 1993 Jun 30; 55(2):167-83. PubMed ID: 8357526
    [Abstract] [Full Text] [Related]

  • 20. Amphetamine-induced rotation reveals post 6-OHDA lesion neurochemical reorganization.
    Lynch MR, Carey RJ.
    Behav Brain Res; 1989 Feb 01; 32(1):69-74. PubMed ID: 2495013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.